Isolated fluorescent protein from clytia gregaria CGFP and use thereof

Details for Australian Patent Application No. 2003292121 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Golz, Stefan; Frank, Ludmila; Markova, Svetlana; Burakova, Ludmila; Vysotski, Eugene

Agent Davies Collison Cave

Pub. Number AU-B-2003292121

PCT Number PCT/EP2003/0132

PCT Pub. Number WO2004/052926

Priority 102 57 354.9 09.12.02 DE

Filing date 26 November 2003

Wipo publication date 30 June 2004

Acceptance publication date 4 March 2010

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

Event Publications

8 April 2004 Complete Application Filed

  Priority application(s): 102 57 354.9 09.12.02 DE

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003292121

18 June 2009 Assignment before Grant

  Bayer HealthCare Aktiengesellschaft The application has been assigned to Bayer Schering Pharma Aktiengesellschaft

4 March 2010 Application Accepted

  Published as AU-B-2003292121

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003292122-PORTIONED WASHING OR CLEANING AGENT

2003292120-New synergistic combination comprising roflumilast and formoterol